Ning JF, Davis ZB, Zeb Q, Hinderlie P, Tuininga K, Wang L, Chaudhary S, Vue Y, Ma J, Zhu S, Zhang Y, Seeman ZJ, Malmberg KJ, Valamehr B, Largaespada DA, Zorko N, Felices M, Cichocki F, Miller JS, Chen CC(2026) iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager Neuro Oncol(in press) DOI 10.1093/neuonc/noag154, PubMed 42434963
